Ganga Pharmaceuticals Limited (BOM:539680)
India · Delayed Price · Currency is INR 14.60
0.00 (0.00%)
At close: Sep 3, 2025
Ganga Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Ganga Pharmaceuticals had annual revenue of 26.37M INR, down -3.60%. Ganga Pharmaceuticals had revenue of 13.26M in the half year ending March 31, 2025, with 7.39% growth.
Revenue
26.37M
Revenue Growth
-3.60%
P/S Ratio
3.27
Revenue / Employee
1.55M
Employees
17
Market Cap
86.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 26.37M | -984.21K | -3.60% |
| Mar 31, 2024 | 27.36M | 1.49M | 5.78% |
| Mar 31, 2023 | 25.86M | 973.18K | 3.91% |
| Mar 31, 2022 | 24.89M | 1.15M | 4.83% |
| Mar 31, 2021 | 23.74M | -7.04M | -22.88% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Hindustan Unilever | 639.28B |
| Infosys | 1,672.76B |